Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Novartis
Novartis
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
INSYS Therapeutics Inc